Gene · 57142
Papers2,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Influences of Emotional Information on Response Inhibition in Gaming Disorder: Behavioral and ERP Evidence from Go/Nogo Task. | Int J Environ Res Public Health | 2022 | 36498338 | PubTator, text mining | PubMed |
| Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis. | Cells | 2022 | 36497029 | PubTator, text mining | PubMed |
| Shared genetic mechanism between type 2 diabetes and COVID-19 using pathway-based association analysis. | Front Genet | 2022 | 36482905 | PubTator, text mining | PubMed |
| IFITM protein regulation and functions: Far beyond the fight against viruses. | Front Immunol | 2022 | 36466909 | PubTator, text mining | PubMed |
| Cofilin Acts as a Booster for Progression of Malignant Tumors Represented by Glioma. | Cancer Manag Res | 2022 | 36452435 | PubTator, text mining | PubMed |
| An ER phospholipid hydrolase drives ER-associated mitochondrial constriction for fission and fusion. | Elife | 2022 | 36448541 | PubTator, text mining | PubMed |
| Disease Activity and Progression in Multiple Sclerosis: New Evidences and Future Perspectives. | J Clin Med | 2022 | 36431119 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Chronic Demyelinating Diseases: Prospects in Treatment and Diagnosis of Autoimmune Neurological Disorders. | Life (Basel) | 2022 | 36431078 | PubTator, text mining | PubMed |
| Pathophysiology and Therapeutic Approaches for Spinal Cord Injury. | Int J Mol Sci | 2022 | 36430308 | PubTator, text mining | PubMed |
| Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to Survival. | Cancers (Basel) | 2022 | 36428591 | PubTator, text mining | PubMed |
| New insights in ferroptosis: Potential therapeutic targets for the treatment of ischemic stroke. | Front Pharmacol | 2022 | 36425577 | PubTator, text mining | PubMed |
| Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease. | Int J Mol Sci | 2022 | 36361826 | PubTator, text mining | PubMed |
Transcriptomic Profiling of Rectus Abdominis Muscle in Women with Gestational Diabetes-Induced Myopathy: Characterization of Pathophysiology and Potential Muscle Biomarkers of Pregnancy-Specific Urinary Incontinence. | Int J Mol Sci | 2022 | 36361671 | PubTator, text mining | PubMed |
| The PINK1 p.Asn521Thr Variant Is Associated with Earlier Disease Onset in GRN/C9orf72 Frontotemporal Lobar Degeneration. | Int J Mol Sci | 2022 | 36361641 | PubTator, text mining | PubMed |
| Nogo-A Regulates the Fate of Human Dental Pulp Stem Cells toward Osteogenic, Adipogenic, and Neurogenic Differentiation. | Cells | 2022 | 36359811 | PubTator, text mining | PubMed |
| MicroRNA and mRNA Expression Changes in Glioblastoma Cells Cultivated under Conditions of Neurosphere Formation. | Curr Issues Mol Biol | 2022 | 36354672 | PubTator, text mining | PubMed |
| Fat storage-inducing transmembrane proteins: beyond mediating lipid droplet formation. | Cell Mol Biol Lett | 2022 | 36348306 | PubTator, text mining | PubMed |
| The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer. | Sci Rep | 2022 | 36344556 | PubTator, text mining | PubMed |
| Restoring After Central Nervous System Injuries: Neural Mechanisms and Translational Applications of Motor Recovery. | Neurosci Bull | 2022 | 36333482 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57142/papers?page=18